I wonder how much this might change in the coming years purely from GLP-1s. Articles like this[0] (which yes, Betteridge's law applies) talk about how it’s pretty likely they’ll be able to be used by everyone. But even now, taking people with cardiovascular high probabilities and dropping that risk way down purely by giving them the feeling that they’re more full more frequently is crazy to think about. Not sure opinions here but I’m at the point of telling my parents they should both be on these right now in their upper 60s.

Some people shrug it off or claim that they’re higher status because they lost weight via diet and exercise, but I map that to people who think they’re better programmers because they don’t use llms for coding, when the real result is what matters. Similar to people thinking AI slop, there are news articles about what happens if you stop GLP-1s and gain the weight back. But the stories of people who either continue to microdose, or also learn the feelings of their body and how it differs have long term success. Similar to those who know how to work with llms get good results, but the news is about how smarter people don’t use it.

All very interesting subjects. What a world we’re in.

[0] https://www.derekthompson.org/p/why-does-it-seem-like-glp-1-...